Selective laser trabeculoplasty (SLT) is an advanced non-thermal nanosecond laser treatment, clinically proven by the LiGHT trial to be a safe and effective first-line therapy for the treatment of primary open-angle glaucoma or ocular hypertension.1
Ellex’s Tango Reflex Neo, incorporating proprietary SLT technology, delivers advanced energy control, a homogenous sharp-edged aiming beam, and the industry’s fastest firing rate of up to 4 Hz (four shots per second).* It’s a capability that’s being used every day by physicians worldwide to visualise the trabecular meshwork in greater detail, and to perform procedures faster and with improved accuracy, delivering better patient outcomes – reliably, accurately, and safely.
Contact: Ellex Medical Lasers (AUS) 08 7074 8200
* Based on system performance testing. Data on file. Ellex Medical.
Reference
- LiGHT study, The Lancet. 393.10175
